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ABSTRACT 
Research on the cognitive and psychosocial effects of treatment for childhood brain tumors has 
consistently found deficits in these areas. However, the connections between these deficits, as 
well as their biological basis, are largely unidentified. This study used cognitive tests, parent 
questionnaires, and functional neuroimaging to further examine possible deficits in these areas of 
functioning. Brain tumor survivors had increased levels of neurocognitive and psychosocial 
problems, as well as decreased brain activation during working memory tasks as compared with 
healthy controls. Additionally, brain activation and social problems were found to be the best 
predictors of internalizing problems. These results further clarify the deficits observed in brain 
tumor survivors and support the hypothesis that brain tumor treatment is associated with 
inhibited brain activation.  
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INTRODUCTION 
Among adolescents, brain and central nervous system (CNS) tumors are the second most 
common malignancy and the most common type of solid tumors (Butler, 2006). Brain tumors 
represent 20-25% of all malignancies among children under age 15 and are also one of the most 
devastating illnesses, ranking as the second leading cause of disease death among children under 
the age of 20 (Panigraphy et al., 2009).  
Both the high level of occurrence, as well as the harsh course of the disease and its treatment, 
has led to a rapid growth in research of the disease and methods of treatment. As a result of 
significant advances in treatment, survival for childhood brain tumor patients is over 60% (Ness 
et al., 2007). As survival rates have increased, treatment has been able to transform the diagnosis 
of a brain or CNS tumor in a child from a situation in which the sole focus was survival of the 
patient, to one that is now much more complicated and encompasses the consequences of 
treatment 5 or 10 years later. Rather than focusing exclusively on overcoming the main obstacle 
of surviving the tumor, research with these patients and their healthcare providers is now 
examining more in depth the long-term results of the disease and treatment.  
The standard of care for newly diagnosed brain tumor patients currently consists of a 
combination of surgery, chemotherapy, and cranial radiation (Khasraw et al., 2010). In spite of 
significant advances in survival rates, the results of this treatment are often times achieved at a 
high cost. There has been growing evidence that patients who have undergone this treatment 
protocol have cognitive, social, physical, and psychological deficits beyond those of their peers 
(Ness et al., 2007). The current study looked to build on these findings and examine the 
psychosocial and cognitive effects of brain tumor treatment through the use of psychological 
EFFECT OF TREATMENT ON DEVELOPMENT                                                                                                   4 
 
testing. In addition, brain activation, as measured by functional magnetic resonance imaging 
(fMRI), will be examined to begin to create a better picture of the possible neurobiological 
factors related to these cognitive and psychosocial effects. 
 Regarding the long-term cognitive effects faced by childhood brain tumor survivors, 
there is increasing evidence that the brain tumor treatment can lead to negative effects in overall 
cognitive functioning and full-scale intelligence quotient (FSIQ). Spiegler et al. (2007) examined 
subjects ranging from baseline (0-5 years off treatment) to 15 years off treatment and found that 
there was a significant, exponential decrease in IQ score among the brain tumor population when 
compared to normative data. These findings were further supported by a study conducted by 
Merchant and colleagues that also found a significant decrease in IQ following brain tumor 
treatment, although the data was fit to a linear model (Merchant et al., 2009). Perhaps the most 
convincing evidence of the cognitive declines seen in childhood brain tumor survivors is a recent 
meta-analysis that reviewed the literature to create a sample of 1318 subjects. Robinson et al. 
(2010) found that patients who had undergone treatment for a brain tumor during adolescence 
scored almost a full standard deviation below the normal level for their overall cognitive ability. 
These findings were important in moving beyond the identification of cognitive deficits to 
evaluate the severity of the effects of treatment (Robinson et al., 2010).  
In addition to declines in overall cognitive functioning and FSIQ, childhood brain tumor 
survivors have been found to show deficits in executive functioning. Executive functioning 
involves higher order thinking and is related to the ability to synthesize stimuli, form goals and 
aspiration, preparation, attention, verification, and inhibition (Anderson, 2002). As executive 
functioning develops throughout adolescence, it plays an increasingly important role on 
cognitive functioning, behavior, emotion, and social interactions (Anderson, 2002). The broad-
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reaching role of executive functioning makes this a critical area of development and one in 
which deficits are costly. Such deficits have been identified in brain tumor patients, who have 
been found to have lower processing speeds and executive functioning following treatment 
(Kesler et al., 2011). Based on such findings, it is not surprising that brain tumor survivors have 
also been shown to have deficits in sustained attention and attention flexibility, aspects of 
cognitive function that are closely associated with executive functions (Butler et al., 2009). 
Similarly, childhood leukemia survivors exhibited deficits in various attention switching and 
shifting tasks, both between immediate stimuli and between local and global stimuli (Butler et 
al., 2006).  Glauser et al. (1991) also found deficits among brain tumor patients in visual and 
perceptual abilities.  
When examining such results, it is important to keep in mind the potential practical effects of 
declines in these different cognitive areas.  One major outcome among children and adolescent 
populations is decreased performance in school. Testing children years after diagnosis, Mabbott 
and colleagues found that reading, spelling, and mathematics performance was lower in children 
who had received treatment for medulloblastomas and ependymomas (Mabbott et al., 2005). 
This decrease was extrapolated to fit a quadratic pattern of decline and was found not only 
through direct cognitive testing, but also through parent and teacher ratings of school 
performance- both of which decreased following diagnosis and treatment (Mabbott et al., 2005). 
 Just as important as the cognitive deficits faced by survivors of childhood brain tumors 
are the psychosocial effects. As previously described, cognitive and social or behavioral effects 
are often interconnected and may be the outcome of a common impairment (Anderson, 2002). 
Children spend a large portion of their time in highly social environments such as school or day 
care, where they are expected to interact with one another (Bonner et al, 2008). Such interactions 
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and sociability are crucial in the normal development of a child and many negative effects, both 
short and long-term, can arise if a child has difficulties in this area (Brengden et al., 2002).  
One of the leading studies regarding both the cognitive and social effects of cancer 
treatment, including that of brain tumors, is the Childhood Cancer Survivor Study (CCSS). 
Incorporating 26 sites and over 14,000 cancer patients, the study represents the most 
comprehensive database of childhood cancer survivorship outcomes. Using this data, Hudson 
and colleagues analyzed the psychological functioning of over 9000 pairs of survivors and 
siblings, finding that cancer survivors were significantly more likely to report mental health 
problems than their non-cancer siblings (Hudson et al., 2003). More specifically, survivors were 
found to be 1.5 times more likely to show depressive/anxiety symptoms and 1.7 times more 
likely to have antisocial problems when compared to their non-cancer siblings (Schultz et al., 
2007). 
 The high variability of the measured social and behavioral effects of adolescent cancer 
treatment has led to a somewhat conflicting picture of the challenges facing this population. 
Although Schultz and colleagues (2007) found that brain tumor patients showed significantly 
higher levels of internalizing problems, a meta-analysis conducted to assess the social, 
emotional, and behavioral outcomes in childhood brain tumor patients found little conclusive 
evidence that this population experienced increased internalizing or externalizing problems 
(Fuemmeler et al., 2002). However, there was significant evidence that these patients 
demonstrated lower social competence when compared to normative data and healthy controls 
(Fuemmeler et al., 2002).  Additional studies involving teacher and parent evaluation of school-
age brain tumor patients did not endorse an increase in internalizing or externalizing problems at 
baseline or over time (Mabbott et al., 2005). However, once again, social problems did appear to 
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increase over time through an estimated increase in CBCL and teacher rating scores (Mabbott et 
al., 2005).  
 Despite the mixed evidence regarding the specific problems manifested by childhood 
brain tumor survivors, it is becoming increasingly clear that this population does indeed suffer 
social deficits. These effects are not only present during the disease and treatment, but long after 
these patients have recovered. Comparing self, teacher, and parent scores on the Revised Class 
Play and the Liking Scale (Masten et al., 1985), children were matched to others in their class 
based on gender, age, and other socioeconomic factors. Children who had been diagnosed with 
brain tumors received fewer friend nominations from the other children in the class and were 
also reported as more socially isolated, sick, fatigued, and absent by self, teacher, and parent 
ratings (Vannatta et al., 1998). Such findings highlight the manifestations of the psychological 
and social deficits faced by these children into everyday situations. These deficits not only affect 
the survivors on a personal level, but also on an outwardly noticeable level, evident to both 
teachers and parents.  
 When examining these deficits, it is important to not only view them on the larger scale 
of everyday implications and outwardly evident effects, but also to look at the more basic 
underpinnings that possibly lead to the larger effects. Facial expressions are a crucial component 
of effective communication and social functioning because of their role as one of the “complex 
and varied social cues” that add information beyond what is directly said (Bonner et al., 2008). 
Therefore, it follows that deficiencies in interpreting facial cues and expressions would lead to 
larger social consequences. In fact, when compared to children suffering from rheumatoid 
arthritis, and, after being controlled for IQ levels, childhood brain tumor survivors had a 
significantly impaired ability to identify and interpret adult facial expressions (Bonner et al., 
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2008). Thus, it would be reasonable to extrapolate the possibility of such a deficit to play a role 
in some of the larger-scale deficiencies, such as those seen in the classroom setting.   
 Although many of the cognitive, psychological, and social effects of adolescent brain 
tumor treatment have begun to be identified, there has been a clear lack of progress in 
understanding the neurobiological basis and causes of these deficits. The current study not only 
measured the social, psychological, and cognitive deficits related to brain tumor treatment, but 
also evaluates the underlying processes that create deficiencies in these different areas and how 
they relate to brain activation. In order to test the neurobiological effects of the stress faced by 
adolescent brain tumor survivors, as well as the direct neurobiological effects of the treatment 
they undergo, the current study used fMRI methods. In the past decade, fMRI has emerged as the 
leading way to measure and monitor brain activity at the neuronal level. fMRI measures neuronal 
activity through “metabolic and hemodynamic responses” that correspond to changes in neuronal 
activity in the brain (Zou et al., 2004).  For example, Zou and colleagues (2005) were able to 
demonstrate that fMRI was an effective measurement for brain activation in cancer populations. 
These researchers assessed the brain activation of subjects when shown a visual stimulus and 
found that brain activity that is “qualitatively similar, but quantitatively different” between 
cancer patients and healthy controls (Zou et al., 2005).   
In addition to ascertaining that there is an observable, neurological response to stress and 
that the measurement is effective in the population of interest, it is also essential to be able to 
map the variables of interest (i.e., social and cognitive deficits) onto brain activity observed via 
fMRI. Brain activation as measured by fMRI has been found to correlate well with psychological 
testing scores and cognitive functioning (Kesler et al., 2011). For example, increased processing 
speed, cognitive flexibility, and verbal/visual declarative memory scores were shown to be 
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associated with increased pre-frontal cortex activation (Kesler et al., 2011). In a similar study 
involving survivors of adolescent lymphocytic leukemia, fMRI was used to test brain activation 
during an N-back task testing working memory (Robinson et al., 2010). Like the Kesler study, 
this study utilized both fMRI and psychological tests (i.e. WISC, D-KEFS) to measure the 
cognitive levels of the participants. However, unlike the Kesler et al. study, Robinson and 
colleagues compared the neuronal activity of the ALL group to a group of healthy controls 
(Robinson et al., 2010). This study found that the ALL group underperformed on higher level 
tasks and displayed significantly greater activation in the areas underlying working memory and 
error monitoring when compared to the controls (Robinson et al., 2010). Both of these studies 
support the conclusion that the brain activation and neurocognitive performance are correlated. 
However, there has been much inconsistency in the findings regarding the neurocognitive 
underpinnings of cognitive deficits in adolescents who have suffered from cancer. As mentioned, 
Robinson et al. (2010) found that lower scores on measures of cognitive output and executive 
functioning were associated with increased neuronal activation in the prefrontal cortex of the 
pediatric ALL survivors.   This is in contrast to the findings of the Kesler group in which 
activation increased with improved cognitive performance. Both the Wisconsin Card Sorting 
Task used by Kesler et al. and the N-back task used by Robinson et al. are designed to test 
executive function and thus a similar relationship between performance and neuronal activity 
would be expected. The current study further addressed the relationship between brain activation 
in the prefrontal cortex and performance on cognitive tasks. 
Although the link between cognitive performance and brain activation has begun to be 
more heavily documented, the mapping of specific brain areas that correspond to social cues is a 
recent discovery (Masten et al., 2009). For example, when participating in a social exclusion task 
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during fMRI, adolescents displayed insular and prefrontal activity that was related to self-
reported distress (Masten et al., 2009). Overall, adolescents with higher self-reported and parent-
reported distress levels showed “greater neuronal evidence of emotional distress” (Maten et al., 
2009). These findings are crucial in establishing the ability to track social functioning effects 
through fMRI measurement.   
 The current study examined neurobiological correlates of not only cognitive functioning, 
but also social functioning. fMRI has been used in cancer populations mainly to examine 
cognitive deficits. However, based on previous findings that deficits in executive functioning and 
cognitive ability are correlated with increased behavioral and social problems in ALL and 
maternal depression populations (Campbell et al., 2009), it could be expected that these results 
can be extrapolated to the brain tumor group. However, no research has directly compared 
executive function levels to brain activation during socialization tasks.  The current study also 
serves as one of the first studies using fMRI to examine cognitive function in childhood brain 
tumor survivors. Although MRI has been used to diagnose brain tumors and evaluate treatment 
for over 25 years, studies have examined the broader range of adolescent cancer patients, 
adolescent lymphocytic leukemia patients, and healthy children (Panigraphy et al., 2009). 
However, as shown by the Spiegler et al. and Merchant et al. studies, brain tumor patients show 
high levels of cognitive deficits following treatment and are thus an important group to monitor 
(Spiegler et al., 2003, Merchant et al., 2010). A more fundamental and in depth understanding of 
the biological processes underlying detrimental cognitive and social effects is crucial for the 
brain tumor population.     
 The goals of this study were to examine differences in executive functioning, 
anxious/depressive symptoms, and social functioning between brain tumor survivors and healthy 
EFFECT OF TREATMENT ON DEVELOPMENT                                                                                                   11 
 
controls using neuropsychological assessment and BOLD signal activation during fMRI. The 
following hypotheses were tested:  
Hypothesis 1. Brain tumor survivors will perform more poorly than matched 
healthy controls on measures of executive function, cognitive flexibility and inhibition, 
measures of social problems, as well as measures of anxious and depressive symptoms. 
Hypothesis 2. Following findings that support a strong connection between early 
social difficulties and anxious/depressive problems (Hymel et al., 2008), it is expected 
that differences in social problems will account for differences in anxious/depressive 
symptoms between the brain tumor survivors and healthy controls. In addition, these 
differences in social problems will explain the expected correlation between cognitive 
performance and anxious/depressive symptoms. 
Hypothesis 3. Brain tumor survivors will perform more poorly than healthy 
controls on the N-back task during the scan as compared to healthy controls and there 
will be differences in prefrontal brain BOLD activation between the two groups during 
this task. Findings in this area have been mixed, and thus this question is more 
exploratory in nature. However, it is possible to expect a lower level of activation in the 
prefrontal cortex of the brain tumor survivors when compared to healthy controls because 
of the demyelination and necrosis of white matter following brain tumor treatment 
(Burger and Bokyo, 1991). Additionally, it is expected that BOLD activation may play a 
role in the differences in neurocognitive functioning between the two groups. 
METHODS 
Participants 
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 The sample included 20 adolescents (12 male) who have been treated for a brain tumor 
and 20 (9 male) healthy control participants. The brain tumor participants were recruited from 
the Monroe Carell Children’s Hospital Pediatric Oncology Clinic and the healthy controls were 
recruited from the Vanderbilt University Study Finder program. Upon enrollment in the study, 
brain tumor survivors were an average of 12.15 years old (SD = 2.72) and healthy controls were 
12.4 years old (SD = 2.98). 18 brain tumor survivors and 12 healthy controls self-identified as 
Caucasian and then next most represented ethnicity was Black or African American with one 
brain tumor survivor and six healthy controls self-identifying. One participant in each group self-
identified as Asian or Pacific Islander and one healthy control self-identified as Latino. 
Demographic information for participants can be found in Table 1. Between groups t-tests and 
chi-square analyses were conducted to examine potential differences between the two 
populations. These analyses found that brain tumor survivors and healthy controls were similar 
regarding age (t = .277, p = .783), gender (χ2 = .91, p = .342), race (χ2 = 5.77, p = .123), 
parent/main caregiver (χ2 = 3.24, p = .072), and household income (χ2 = 1.059, p = .589). 
However, there was a significant difference in the education level of the parents of brain tumor 
survivors when compared to healthy controls (χ2 = 4.44, p = .035). Despite this difference, the 
results indicate that survivors and healthy controls were adequately matched and did not differ 
significantly in terms of demographic characteristics.  
Procedure 
Letters were sent to the parents or guardians of pediatric brain tumor patients through the 
Monroe Carell Jr. Childrens’ Hospital hematology/oncology department. Healthy controls were 
recruited using the Vanderbilt University StudyFinder website. The families were then contacted 
by the research coordinator for this project who conducted a phone screen to determine if the 
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participants met the inclusion criteria. An appointment was then set up for the functional 
neuroimaging and psychological testing components of the study. The family could either 
arrange to do this all in one full day or divide it between two half days.  
 Study participation included a neurocognitive assessment battery, completion of 
questionnaire measures, and a neuroimaging session. On the scheduled appointment day, the 
participant completed the battery of neurocognitive testing administered by a psychologist or 
trained graduate student. These tests included measures of overall cognitive functioning, 
memory, and executive function. Additionally, parents and children completed several 
questionnaire measures assessing various domains of functioning, including psychosocial, 
emotional, and behavioral problems, and executive function. 
 All imaging was conducted on a 3Tesla MR scanner (Philips Medical Systems, The 
Netherlands) dedicated for research. The functional neuroimaging session began with an 
introduction to the memory task (N-back) and social task (Cyberball) during which the examiner 
explained how to answer and respond to the different tasks. The child was given a chance to run 
through one full cycle of the N-back on a computer screen for practice to insure they understood 
the task. The child was then shown a mock scanner to become accustomed to the environment of 
the actual scan. The child was also introduced to the headset and response pad need for the N-
back tasks during the mock scanner session. After any additional questions were answered, the 
.child was taken back to the scanner and was put into the scanner by a certified technician. The 
response pad was given to the child, a pulse oximeter was attached to the participant’s index 
finger to record heart rate, and a respiration belt was placed over the participant’s diaphragm to 
record respiration rate.  
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 The imaging protocol was then followed, with the N-back task controlled via a computer 
in the adjacent room. Participants were able to respond to questions using buttons on the 
response pad, and they were able to communicate with study personnel throughout the scan via 
headphones and a microphone. The entire protocol of anatomic and functional scans took 60-80 
minutes. Following the scan, the child was debriefed and the session was formally concluded. 
Measures 
Neurocognitive Functioning. The Delis-Kaplan Executive Function System (D-KEFS) 
was used to evaluate executive functioning (PsychCorp, San Antonio, TX.). This test has both 
high reliability and validity and is normalized based on a sample of 1,750. This included the 
Color-Word Interference Test, which tests verbal inhibition and cognitive flexibility, both of 
which have been shown to be affected in cancer populations (McCoy, 2009; Butler et al., 2009)). 
The Color-Word Interference test is based off of the Stroop Task and contains four conditions. 
The first two, color naming and word naming, test basic component functions and involve 
presenting the participant with a page either containing a series of red, blue, and green squares or 
the words “red,” “blue,” and “green.” The subject is then asked to say the color in the box or read 
the word on the page as quickly as possible. The last two tasks, inhibition and 
inhibition/switching, require an inhibition of the natural response and mental flexibility (McCoy, 
2009). In the inhibition trial, the participant is presented with a series of the words “red,” 
“green,” and “blue” written incongruently in red, green, or blue ink. The participant is asked to 
say the color of the written word, not the ink. This condition is most closely related to the Stroop 
Task. The final condition, inhibition/switching, is similar to inhibition, with the addition of boxes 
around half the words. For these boxed words, the participant must say the name of the color of 
the ink as opposed to the word itself. Thus, the participant is switching between two sets of 
instructions throughout the task (Lippa & Davis, 2009).  
EFFECT OF TREATMENT ON DEVELOPMENT                                                                                                   15 
 
The Behavior Rating of Executing Functioning was also used to measure executive 
functioning of both the brain tumor survivors and healthy controls. The BRIEF is a questionnaire 
filled out by the parents of the survivors and healthy controls that has demonstrated both high 
internal consistency (alpha = .80-.98) and test-retest reliability (rs = .82) (PAR Inc., Lutz, FL.). 
The BRIEF consist of 86 items that form eight clinical scales. Of particular interest for this study 
are the behavioral regulation scale, which involves emotional control, inhibition, and shift, and 
the shift scale, which measures the ability to change from one task to another.  
Emotional and Behavioral Problems. Parents provided information about the emotional 
and social problems of survivors and healthy controls by completing the Child Behavior 
Checklist (CBCL; Achenback & Rescorla, 2001). This test measures symptoms of anxiety 
problems, internalizing symptoms, and social problems among others. These scales have strong 
test-retest reliability and criterion validity. In the following analyses, social problems and 
anxious/depressive symptoms will be assessed using the Social Problems, Anxiety Problems, and 
Internalizing Symptoms scales.   
Functional Neuroimaging. During their first functional scan, participants completed the N-
back task, which is designed to assess working memory. A letter version of the visual N-back task 
(Barch, Sheline, Csernansky, & Snyder, 2003) has been developed, and involves sequences of 
uppercase consonants. In the 0-back condition, participants were instructed to respond to a single 
target (i.e., V). In the 1-back condition, participants were instructed to respond only when the 
consonant was identical to the one preceding it (e.g., M, M). In the 2-back condition, participants 
responded only when the consonant was identical to the one presented two trials prior (e.g., M, T, 
M), and in the 3-back condition, participants responded when the consonant was identical to the one 
presented three trials prior (e.g., M, T, F, M). Each condition was presented three times in order of 
increasing difficulty, for a total of 12 blocks. Each block contained 15 consonants, and 3 of these 
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consonants required a response, for a total maximum accuracy score of 45. This task has been used 
effectively with children in this age group with no adverse effects (Robinson, Livesay, et al., 2010). 
N-back task performance data were extracted using ePrime software (Psychology Software Tools 
Inc., Pittsburgh, PA). Accuracy was calculated for each participant at each level of N-back difficulty.  
 Preparation of Imaging Data for Analysis. Imaging produced 33 oblique axial slices 
parallel to the AC-PC plane (Anterior Commissure, Posterior Commissure).  All of the data from 
the functional neuroimaging sessions were analyzed using Brain Voyager QX software (Brain 
Innovation B. V., Maastricht). The images were first analyzed for motion and if motion exceeded 
the threshold of 3mm, the data from the corresponding N-back condition was removed. Next, the 
functional imaging was imposed onto the patient’s anatomical scan that was then adjusted to fit a 
standardized space known as Talairach. Talairach transformation allows spatial comparisons in 
brain activation to be constant across different participants despite variability in brain 
morphology. Thus, activation in voxel 12 of brain A will correspond to the same structural area 
as voxel 12 of brain B, even if the brains are of varying sizes and morphologies. Following 
Talairach transformation, clusters of interest were identified based on the level of brain 
activation in that area. If 6 or more functional voxels within a cluster were activated, the region 
became labeled as a cluster of interest and was examined during data analysis.  
Design 
 Study hypotheses were analyzed as follows: 
Hypothesis 1. Independent-samples t-tests were conducted to examine whether 
brain tumor survivors performed more poorly than healthy controls on measures of 
executive function, measures of social problems, and measures of anxious and depressive 
symptoms. Measures included the DKEFS, BRIEF, N-back, and CBCL.  
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Hypothesis 2. Linear regression models were conducted to determine the 
relationships between social problems, anxious/depressive symptoms, and neurocognitive 
functioning. Measures included the DKEFS and CBCL. 
Hypothesis 3. An independent-samples t-test was conducted to examine whether 
brain tumor survivors differed from healthy controls in prefrontal BOLD activation 
during the N-back task. BOLD activation was also included in the linear regression 
models to determine if it best accounted for the variance found between brain tumor 
survivors and healthy controls on measurements of social problems.    .     
RESULTS 
Hypothesis 1 
 It was predicted that brain tumor survivors would perform more poorly on measures of 
executive function, social problems, and anxious/depressive symptoms. Means and standard 
deviations for measures of executive function, social problems, and anxious/depressive 
symptoms are reported in Table 2. On both measures of executive function taken from the 
BRIEF, the mean T scores of the brain tumor survivors fell above that of the normative 
population, with the mean score on the Behavioral Regulation scale (58.75) lying almost a full 
standard deviation above the normative mean (higher scores indicate more problems in executive 
function). In contrast, the mean T score for the healthy controls for each of these measures were 
approximately equal to that of the normative population. Comparisons between the brain tumor 
survivors and healthy controls, calculated using independent samples t-tests, found that the two 
groups differed significantly on both of these measures (Shift Scale: t = 3.01, p = .005; 
Behavioral Regulation Scale: t = 2.60, p = .013). Similar results were indicated by the tests of 
executive function on the DKEFS. The brain tumor survivors’ mean scaled scores were below 
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the normative mean for both tests, whereas the mean scaled scores of the healthy controls were 
slightly above the normative mean for both tests (higher scores indicate better executive 
function). Independent samples t-tests were again used to compare the two groups and found that 
the scaled score means of the two populations differed significantly on the inhibition/switching 
task (t = -.387, p = .000), but not on the word reading task (t = -1.90, p = .065).  
 In regards to social problems, the brain tumor survivors mean T score on the social 
problems scale of the CBCL was over a full standard deviation above the normative mean 
(higher scores indicate more problems). The mean T score of the healthy controls on this scale 
was also above that of the normative sample; however, when an independent-samples t-test was 
used to examine differences between the two groups, the mean T score of the brain tumor 
population was still found to be significantly higher than that of the healthy controls (t = 3.22, p 
= .003). Brain tumor survivors were also found to differ significantly from healthy controls on 
the internalizing (t = 2.80, p = .008) and anxiety problems (t = 2.18, p = .035) scales of the 
CBCL. The brain tumor population had a mean T score approximately one standard deviation 
above average for each of the scales, in contrast to the healthy controls in which the mean T 
score was significantly closer to the average.  
 Taken together, these scores indicate that brain tumors performed more poorly than 
healthy controls on measures of executive function, social problems, and anxious/depressive 
symptoms.  
Hypothesis 2 
Social problems were hypothesized to account for the variance between brain tumor 
survivors and healthy controls in anxious/depressive symptoms and serve as an intermediate 
between cognitive performance and anxious/depressive symptoms. Pearson correlations were 
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used to measure the connection between social difficulties and anxious/depressive symptoms, as 
well as the association between neurocognitive performance and anxious/depressive symptoms. 
The Pearson correlation values are reported in Table 3. From these analyses, it was found that 
social problems were significantly correlated with anxious/depressive symptoms, as measured by 
the T scores for the internalizing and anxiety problems scales (internalizing: r = .53, p < .001; 
anxiety problems: r = .63, p < .001). In both cases, the correlation was positive, indicating a 
direct relationship between social problems and anxious/depressive symptoms.  
Regarding the relationship between neurocognitive performance and anxious/depressive 
symptoms, these two variables were found to be significantly correlated based on multiple 
measures. Both the executive function scales of the BRIEF and DKEFS correlated significantly 
with the anxiety problems scale of the CBCL. Both scales from the BRIEF were positively 
correlated to anxiety problems (shift: r = .73, p < .001; behavioral regulation: r = .78, p = .001) 
and both scales from the DKEFS were negatively correlated to anxiety problems (word reading: 
r = -.48, p = .002; inhibition/switching: r = -.37, p = .018). It is important to remember that 
higher scores on the BRIEF correspond to increased deficits in executive function. Thus, both the 
positive correlations between BRIEF scores and anxiety problems, and the negative correlations 
between DKEFS scores and anxiety problems both correspond to an inverse relationship between 
executive function performance and anxiety problems. This inverse relationship holds true for 
executive function and anxious/depressive problems as well. As executive function increases, 
anxious/depressive symptoms tend to decrease as demonstrated by the negative correlation 
between the internalizing T score on the CBCL and the scaled score on the DKEFS CW reading 
task (r = -.41, p = .008). However, unexpectedly, the inverse correlation between executive 
function and anxious/depressive symptoms only approached significance for the relationship 
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between the DKEFS CW inhibition/switching score and internalizing problems (r =-.29, p = .07). 
Despite this, overall these correlations support previous findings of a direct relationship between 
social difficulties anxious/depressive symptoms (Hymel et al., 2008), as well as supporting a 
direct relationship between cognitive performance and anxious/depressive symptoms.  
 In order to examine the role of social problems in accounting for the differences in scores 
between brain tumor survivors and healthy controls on anxious/depressive symptoms and 
determine if they explain the correlation between cognitive performance and anxious/depressive 
symptoms, a linear regression was used. The beta and R-squared values for the four step model 
are presented in Table 4 and the model is outlined in Figure 1. When executive function was 
added to the model, it better predicted differences in anxiety problems than group and the beta 
value approached significance (t= -1.9, p = .07). However, when social problems were added 
they better accounted for the variance in anxiety problems than group, executive functioning, or 
BOLD activation (t = 4.05, p < .001). Social problems remained the best predictor of 
anxious/depressive symptoms when the internalizing scale (t = 2.53, p = .017) of the CBCL was 
used instead of the anxiety problems scale of the CBCL. A second linear model was created to 
determine what factor best accounted for the variance found between healthy controls and brain 
tumor survivors on the social problems scale of the CBCL. The beta and R-squared values for 
the three-step model are presented in Table 5 and the model is outlined in Figure 2. Contrary to 
the hypothesis that neurocogntive performance would account for the variance in social 
problems, supporting the idea that social problems serve as an intermediate step between 
cognitive performance and anxious/depressive symptoms, the variance in social problems was 
best accounted for by BOLD activation in the prefrontal cortex. Thus, these results supported the 
hypothesis that social problems would best account for the variance in anxious/depressive 
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symptoms, but contradicted the hypothesis that social problems are an intermediate step between 
cognitive performance and anxious/depressive symptoms.  
Hypothesis 3 
 Regarding functional neuroimaging, brain tumor survivors were expected to perform 
more poorly on the N-back task during the scan as compared to healthy controls and to show 
decreased BOLD activation while completing the task. Additionally, BOLD activation was 
expected to play a role in predicting the variability in the scores on the social problems scale of 
the CBCL. The means and standard deviations for the total accuracy for both brain tumor 
survivors and healthy controls on each of the three N-back levels are reported in Table 2. 
Independent-samples t-tests were run to evaluate the differences in accuracy between the two 
groups. These tests indicated that, although brain tumor survivors and healthy controls did not 
differ in total accuracy on the 0-back, 1-back, or 2-back conditions, brain tumor survivors 
performed significantly more poorly on the 3-back condition. It was only during the most 
difficult portion of the task that the two groups differed significantly. The means and standard 
deviations for the BOLD activation of each group while performing the 3-back task are also 
recorded in table 2. The area analyzed, Brodmann’s area (BA) 32, corresponds to the dorsal 
anterior cingulated cortex (D-ACC), located in the prefrontal cortex. The prefrontal cortex is 
recruited during complex tasks that require skills such as working memory, and more 
specifically, BA 32 has been found to be activated during executive function tasks (Robinson et 
al., 2010). Consistent with the hypothesis, the results of an independent samples t-test indicated 
that the healthy controls had significantly higher activation in BA 32 during the 3-back task 
when compared to brain tumor survivors.  
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 Lastly, a linear regression model was run to determine which factor best predicts the 
variance seen between healthy controls and brain tumor survivors on scores of social problems. 
The 3-step model included group, CW inhibition/switching, and BA 32 BOLD activation as 
independent variables, and social problems (CBCL) as the dependent variable. The beta and R-
squared value for this regression are listed in Table 5 and the model is outlined in Figure 2. To 
test the hypothesis that BOLD activation in BA 32 would best predict variance in neurocognitive 
performance, a linear regression model was run with CW inhibition/switching as the dependent 
variable. This test indicated that the variance in neurocognitive performance was best accounted 
for by group (t = 2.31, p =.029), contradicting the original hypothesis. However, as described 
during the results of hypothesis 2, BOLD activation in BA 32 was found to be the best predictor 
of social problems. In order to further test this connection, a linear regression model was created 
with BOLD activation in BA 32 as the dependent variable and measures of executive function 
and group as the independent variables. This test indicated that BOLD activation in BA 32 is 
best predicted by group status (brain tumor survivors vs. healthy controls). From these analyses, 
a theoretical model can be created in which group predicts BOLD activation, which in turn 
predicts social problems, which lastly predicts anxious/depressive symptoms (Figure 3).  
DISCUSSION 
The increased effectiveness of cancer treatments, including surgery, chemotherapy, and 
radiation, has led to momentous gains in survival rates for cancer patients, including those who 
have suffered from childhood brain tumors. However, these treatments carry potentially heavy 
adverse consequences. This study sought to examine some of these deficits in cognitive and 
psychosocial functioning in the largely understudied group of pediatric brain tumor survivors.  
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Through the use of parent questionnaires and standardized testing, the executive function 
performance of both the healthy controls and brain tumor survivors were measured. Executive 
function is an essential development in cognitive capabilities that involves a more complex level 
of thinking and understanding crucial for mental control and self-regulation (Anderson, 2002). 
Previous research indicates that brain tumor patients show significant decreases in executive 
function following treatment (Kesler et al., 2011). Based on these findings, it was expected that 
brain tumor survivors would show lower levels of executive function when compared to healthy 
controls. Indeed, the brain tumor patients tested in this study were found to have decreased 
executive performance when compared to healthy controls, both based on parent questionnaires 
as well as on scores from a complex task involving cognitive flexibility and inhibition. These 
findings reemphasize the presence of consistent deficits in neurocognitive function for survivors 
of childhood cancer, and more specifically in regards to brain tumor survivors. It is essential to 
identify the specific deficits facing these populations in order to move closer to potentially 
alleviating them.  
In addition to neurocognitive functioning, differences in psychosocial functioning were 
also examined. Although somewhat mixed, there have been a substantial number of findings that 
indicate large social deficits arising in brain tumor and other cancer populations (e.g., Schultz et 
al., 2007; Mabbott et al., 2005). Consistent with findings that cancer survivors display lower 
social competency levels, it was hypothesized that brain tumor survivors would have higher 
levels of social problems when compared to healthy controls. Additionally, based on data 
supporting connections between early social problems and the development of 
anxious/depressive symptoms (Hymel et al., 2008), brain tumor survivors were expected to show 
increased anxious/depressive symptoms when compared to healthy controls. Comparisons 
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between the two groups on self-report scales of social problems, internalizing symptoms, and 
anxiety problems supported these hypotheses. Brain tumor survivors were much more likely to 
show both social problems and anxious/depressive symptoms as measured by parent reports. 
Such findings are essential in clarifying the picture of the specific social deficits faced by brain 
tumor survivors and, coupled with the deficits seen in neurocognitive function, emphasizing the 
harsh reality of the consequences of cancer treatment.  
The second major topic examined in this study was the relationships between 
psychosocial functioning, cognitive performance, and anxious/depressive symptoms. As 
expected, there was a strong correlation between cognitive performance and anxious/depressive 
symptoms. In addition, the variation in anxious/depressive symptoms was better accounted for 
by executive function performance than group status alone. When social problems were added to 
the model, they best predicted anxious/depressive symptoms, supporting the hypothesis that they 
may be an intermediate step between executive function and anxious/depressive symptoms. 
However, when a regression model was run to determine the best predictor of social problems, it 
was not found to be executive function, but rather BOLD activation in the prefrontal cortex, a 
relationship that will be addressed further shortly. 
 The third major topic addressed by this study was the identification of potential 
neurobiological differences between brain tumor survivors and healthy controls using functional 
neuroimaging and a verbal memory task. Following previous research regarding cognitive 
deficits in brain tumor populations, it was hypothesized that these declines would hold true for 
performance on a working memory task conducted within the scanner as well. Indeed, brain 
tumor survivors performed significantly more poorly on the most complex level of the N-back 
working memory task when compared to healthy controls. In addition to documenting the 
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presence of such deficits, this study served as one of the first to examine the potential brain 
activation response underlying these negative neurocognitive effects. Although little research has 
been done regarding brain activation during working memory tasks for brain tumor survivors, 
there have been multiple studies examining this response in Acute Lymphocytic Leukemia 
survivors. However, the results of such studies have been mixed. Some of these studies have 
found that ALL survivors show increased levels of brain activation than healthy controls when 
completing an equally difficult task, indicating a compensatory mechanism (Robinson et al., 
2010).  In contrast, other studies have found that cancer survivors perform more poorly on 
executive function tasks and this corresponds to decreases in brain activation (Kesler et al., 
2011). It was predicted that the brain tumor survivors in this study would show decreased brain 
activation when compared to healthy controls because of the demyelination effect and necrosis 
of white matter that often results from the radiation therapy included in brain tumor treatment 
(Burger & Bokyo, 1991). The findings of this study supported this hypothesis and differ from the 
results found in ALL survivors by Robinson et al. (2010), with brain tumor survivors showing 
decreased activation in the prefrontal cortex compared to healthy controls. Additionally, 
increased BOLD activation in the prefrontal cortex correlated significantly with better executive 
function performance, decreased internalizing symptoms, and decreased social and anxiety 
problems. These findings offer strong support for the theory that the neuronal damage caused by 
radiation therapy may lead to decreases in brain activation that are both cognitively and 
psychosocially detrimental. 
More specifically, the area in which these differences in activation occurred was BA 32, 
which corresponds to the dorsal anterior cingulated cortex (D-ACC). The D-ACC is one of the 
primary brain regions underlying working memory and is involved in task evaluation, 
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monitoring, and error detection (Robinson et al., 2010). The D-ACC is also fundamental to 
circuits responsible for cognitive processing and tasks that require target assessment and 
attention to language (Staffen et al., 2005). Robinson et al. (2010) found differences in activation 
of the D-ACC between healthy controls and ALL survivors, and this study further supported 
these findings and the theory that the D-ACC is one of the brain regions that may be most 
affected by cancer treatment.  
fMRI was also used to examine potential brain activation differences corresponding to 
the variance in social functioning and neurocognitive performance observed between groups. It 
was hypothesized that BOLD activation would serve as a strong predictor of executive function 
performance based on the known functions of the D-ACC and prefrontal cortex. However, 
BOLD activation in the D-ACC did not better predict executive function performance than group 
status. The lack of a connection between BOLD activation and executive function performance 
was also evidenced by the largely non-significant correlations found between the two variables. 
However, although BOLD activation did not strongly predict executive function performance, 
differences in BOLD activation were found to be the best predictor of the variance in social 
problems.  
These results indicate a hypothesized model in which neuronal differences found in brain 
tumor patients, most likely as a result of radiation therapy and treatment, lead to an impaired 
ability to function socially. It is then a short, and well documented, step to increased levels of 
anxious and depressive symptoms. Such a model supports the conclusion that social problems 
are not solely a social phenomenon, but have a biological basis as well. Noticeably missing in 
this model is executive function performance. Although executive function deficits were found 
to correlate significantly with social problems, they did not best account for the variance 
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observed in social problems nor were they best predicted by BOLD activation in the prefrontal 
cortex as would be expected if they served as an intermediate step between BOLD activation and 
social problems. Although it is possible that neurocognitive performance is not best accounted 
for by BOLD activation in the prefrontal cortex, prior research in this area has indicated 
otherwise, and it may instead be due to the relatively small sample size examined in this study.  
The findings from executive function performance differences, both within and outside of 
the scanner, bring to light another interesting relationship --- group differences in performance as 
a function of task. As mentioned previously, the differences in activation in the D-ACC were 
seen for the 3-back level of the N-back task. This level is the most complex level of the task, 
containing the most letters between the two target stimuli, thus requiring the participant to 
cognitively capture and manipulate the largest amount of information. When the scores of brain 
tumor survivors were compared to those of healthy controls for the progressively less complex 2-
back, 1-back, and 0-back conditions, no significant difference in performance was observed. 
Thus, as has been found in prior research with ALL survivors, these deficits in working memory 
were seen only with the most complex tasks (Robinson et al., 2010). This relationship was 
further supported by comparison of the performance of brain tumor survivors and healthy 
controls on the DKEFS color-word interference subscales. On the word reading task, during 
which the participant is only responsible for reading the name of a color written in black ink, 
brain tumors performed no differently than healthy controls. However, on the 
inhibition/switching task, the most complex subscale of the color-word interference task, 
involving both cognitive inhibition and flexibility, brain tumor survivors performed significantly 
more poorly than healthy controls. Just as with the N-back task, the neurocognitive deficits of the 
brain tumor survivors only became apparent during the most complex tasks. Based on these 
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results, it can be speculated that the damage caused by the treatment of cancers either selectively 
affects the circuitry responsible for these most complex tasks, or affects both complex and 
simple circuits, but in a way that the detrimental effects to the simple circuits can be overcome 
by neuronal plasticity and other recovery mechanisms.  
The results of this study allow for a better, and more complete, understanding of the 
cognitive and social deficits faced by the brain tumor population and, just as importantly, an 
improved understanding the underlying biological basis of these problems. This study is one of 
the first to use neuroimaging to observe both the neurobiological basis of executive function as 
well as differences in the neurobiological processes of brain tumor survivors as compared to 
healthy controls. The multiple measures of neurocognitive and social functioning provide 
conclusive evidence of the significant differences seen in these areas between brain tumor 
survivors and healthy participants. Such knowledge could prove useful in designing more 
effective and less detrimental brain tumor treatment options, in addition to beginning to search 
for methods to alleviate some of these problems.  
However, there are also several limitations that must be taken into consideration when 
interpreting the results of this study. First and foremost, the sample size used in the study was 
relatively small. With 20 participants in both the brain tumor survivor and healthy control group, 
data analyses was limited and the extrapolation of these findings to the larger population of brain 
tumor survivors must be done with caution. In addition, the brain tumor survivor group 
represents a highly heterogeneous sample in regards to brain tumor location and type and the 
treatment received- factors that most likely play a significant role in predicting cognitive and 
social impairments. Regarding the measures used during the study, only a portion of the scales 
for executive function and social deficits were analyzed. In addition, BOLD activation was 
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reported and analyzed here for only one cluster. Such limited analyses may have created a 
skewed or incomplete picture of the challenges facing brain tumor survivors. Lastly, the 
relationships described between the CBCL measures of social problems and anxious/depressive 
symptoms, as well as the executive function measures of the BRIEF, may have been influenced 
by shared method variance. All of these measures were questionnaires completed by the parent 
and, in the case of the CBCL, the two sub-scores were based off of the same overall measure.  
The results of this study suggest many opportunities for continuation and expansion. The 
label of “brain tumor survivor” encompasses a large variety of diagnoses, each corresponding to 
varying locations in the brain, types of cells involved, as well as differing symptoms and 
prognoses. Including all of these diagnoses in one large analysis may overlook distinct 
differences in the cognitive and social implications of each. Much work has been done 
examining the possible factor that contribute to the social and cognitive challenges faced by 
brain tumor survivors, and from this, it has been found that treatment type and tumor location 
have significant influence on the long-term outcomes of brain tumor treatment.   
 Regarding treatment type, radiation is perhaps the most damaging treatment method. 
Radiation therapy has been found to be associated with increased anxious/depressive symptoms, 
attention problems, and antisocial behaviors (Schultz et al., 2007). In addition, radiation dosage 
has been found to correlate positively with the slope of IQ decrease following treatment 
(Merchant et al., 2009). The location of the tumor has been shown to be comparably important in 
predicting outcome, with the level of cognitive and social deficits faced by brain tumor survivors 
being potentially related to the location of the tumor within the brain (Glauser et al., 1991). Thus, 
it would be beneficial to examine cognitive and social deficits with a more homogenous brain 
tumor population, separated based on treatment type, tumor location, or a combination of both.  
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 Perhaps most importantly, a solid identification of the social and cognitive deficits faced 
by brain tumor survivors allows for the possibility of a targeted and effective intervention aimed 
at lessening the detrimental effects. Understanding the specific areas affected most by brain 
tumor treatment allows an intervention to be created to focus on these specific areas. In addition, 
an understanding of the relationships between deficits in these different areas (i.e. social, 
cognitive, and psychological) can lead to an intervention that, through targeting one facet, can 
lead to improvements in multiple domains. In fact, prior studies have shown that training 
working memory can lead to changes in tasks and skills outside of those trained (Buschkuehl et 
al., 2011). Based on these findings and the results from the current study, two general approaches 
to intervention models can be created. The first would involve a bottom-up approach, in which 
the intervention would target working memory in hopes of also improving more complex social 
and behavioral outcomes that are related to working memory performance. The second would be 
a top-down approach in which social and behavioral skills would be targeted in hopes of also 
improving cognitive performance.  
 In conclusion, this study supports prior research indicating the presences of increased 
levels of social, cognitive, and psychological deficits in brain tumor survivors. In addition, the 
study allowed for a greater understanding of the neurobiological basis for such deficits and a 
potential model of how they are related. These findings promise to not only serve as the basis for 
more focused studies involving specific predictive factors in the future, but also for potential 
interventions that will necessarily rely on a basic understanding of the deficits, their connections, 
and their underlying causes. At the core of the current study and these potential future directions 
lies the ultimate goal of improving cancer patient health and prognosis. 
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Table I. Demographics of Brain Tumor Survivors and Healthy Controls  
Variables     BT (n=20)           HC (n=20)              χ2 (p)/ t(p) 
 
Sex  
     Female     8 (40%)  11 (55%)                   .91                          
     Male    12 (60.00%)   9 (45.00%)               
 
Age 
    Mean (SD)                                      12.15 (2.72)                12.4 (2.98)                 .28 
 
Race/ethnicity (n, %) 
     White/Caucasian   18 (90.00%)  12 (60.00%)               5.77           
     Black/African American   1 (5.00%)  6 (30.00%) 
     Latino     0 (0.00%)  1 (5.00%) 
     Asian or Pacific Islander   1 (5.00%)  1 (5.00%) 
 
Main Caregiver (n, %) 
     Biological Mother   17 (85.00%)  20 (100%)                  3.24 (.072) 
     Biological Father    3 (15.00%)  0  (0.00%) 
 
Parent Education (n, %) 
     High School or Less  4 (20.00%)  0 (0.00%)                   4.44*     
     Education Beyond High School  16 (80.00%)  20 (76.60%) 
 
Household Income 
     <$50,000/year    8 (40.00%)  9 (45.00%)                 1.06  
     ≥$50,000/year   11 (65.00%)  11 (55.00%) 
     Rather Not Say                               1 (5.00%)                    0 (0.00%) 
Chi-squares are reported for all variables with the exception of age, for which a t-test was performed 
*p≤ .05, **p< .01, ***p< .001 
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Table II. Mean Scaled Scores and Standard Deviations for Executive Functioning, Social 
Problems, and Anxiety/Depression Variables 
 Brain Tumor Healthy Control t (p) 
 Mean SD Mean SD  
BRIEF Shift Scale T 
Score 
54.00 11.07 49.25 11.36 3.01** 
BRIEF Behavioral 
Regulation T Score 
58.75 10.09 49.60 12.08 2.60* 
DKEFS CW Word 
Reading Scaled Score 
9.30 3.56 11.10 2.13 -1.94 (.059) 
DKEFS CW 
Inhibition/Switching 
Scaled Score 
7.70 3.64 11.30 2.00 -3.87*** 
CBCL Social 
Problems T Score 
61.75 7.00 54.35 7.53 3.22*** 
CBCL Internalizing T 
Score 
60.60 10.61 51.10 10.82 2.80** 
CBCL Anxiety 
Problems T Score 
59.35 7.77 54.00 7.73 2.18* 
3v0-back Cluster 19- 
BA32 
0.02 0.22 .21 .18 -2.71* 
Total Accuracy 0-back 43.56 2.73 44.47 1.94 -1.14  
Total Accuracy 1-back 43.33 2.83 44.59 1.46 -1.63  
Total Accuracy 2-back 41.5 2.55 42.35 3.02 -.90  
Total Accuracy 3-back 37.50 2.60 40.41 2.37 -3.46** 
*p≤ .05, **p< .01, ***p< .001 
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Table III. Correlations Among Executive Function, Social Problems, and Anxiety/Depression 
Scores 
*p≤ .05, **p< .01, ***p< .001 
 
  
 1. 2. 3. 4. 5. 6. 7. 8. 
1. BRIEF Shift Scale 
T Score 
--        
2. BRIEF Behavioral 
Regulation Index 
Scale T Score  
.80*** --       
3. DKEFS CW Word 
Reading Scaled 
Score 
-.62*** .37* --      
4. DKEFS CW 
Inhibition/ Switching 
Scaled Score 
-.54*** -.32* .72*** --     
5. CBCL Social 
Problems T Score 
.69*** .66*** -.34* -.34* --    
6. CBCL 
Internalizing T Score 
.69*** .70*** -.41** -.29 .53*** --   
7.CBCL DSM 
Anxiety Problems T 
Score 
.73*** .78*** -.48** -.37* .63*** .63*** --  
8. 3v0-back Cluster 
19-   BA 32 
-.36* -.28 .16 .23 -.50** -.25 -.15 -- 
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Table IV. Regression Equation Testing Factors of Anxiety Problems as Dependent Variable 
Step Predictors β t(p) R2 R2- 
Change 
F-
Change 
Step 1: Group Group -.35 -2.01* .09 .12 4.06* 
Step 2: CW  
Inhibition/Switching 
Group -.19 -1.04 .16 .10 3.61 
Inhibition/Switching -.35 -1.90 
(.07) 
Step 3: Social 
Problems 
Group .04 .23 .41 .25 13.14** 
Inhibition/Switching -.23 -1.46 
Social Problems .59 3.63** 
Step 4: 3v0-back 
BA 32 BOLD 
Group -.033 -.20 .44 .046 2.54 
Inhibition/Switching -.22 -1.43 
Social Problems .68 4.05*** 
3v0-back .26 1.60 
*p≤ .05, **p< .01, ***p< .001 
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Table V. Regression Equation Testing Factors of Social Problems as Dependent Variable 
Step Predictors β t(p) R2 R2- 
Change 
F-
Change 
Step 1: Group Group -.48 -  
3.01** 
.21 .23 9.08** 
Step 2: CW 
Inhibition/Switching 
Group -.39 -2.20* .22 .03 1.32 
Inhibition/Switching -.20 -1.15 
Step 3: 3v0-back 
BA 32 BOLD 
Group -.24 -1.33 .29 .1 4.23* 
Inhibition/Switching -.19 -1.13 
3v0-back .35 2.06* 
*p≤ .05, **p< .01, ***p< .001 
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Figure 1. Linear Regression Model with Anxiety Problems as Dependent Variable 
Beta values outside of parenthesis are with two variables only. Beta values inside of parenthesis 
represent value after final step of regression. 
*p≤ .05, **p< .01, ***p< .001 
Group CW 
Inhibition/ 
Swithcing 
Social 
Problems 
(CBCL) 
BOLD 
Activation 
(BA 32) 
β=.35* β=-.50** β=.53*** 
β=.-.35* (-.03) 
 
Anxiety 
Problems 
(CBCL) 
β=.15 
(.26) 
β= -.37* (-.22) 
 
β=.68*** (.63***) 
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Figure 2. Linear Regression Model with Social as Dependent Variable 
Beta values outside of parenthesis are with two variables only. Beta values inside of parenthesis 
represent value after final step of regression. 
*p≤ .05, **p< .01, ***p< .001 
Group CW 
Inhibition/ 
Switching 
BOLD 
Activation 
(BA 32) 
β=.53*** β= .23** 
Social 
Problems 
(CBCL) 
β=-.50** 
(.35*) 
β=-.20 (-.19) 
 
β= -.48** (-.24) 
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Figure 3.  Theoretical model representing possible connections between factors contributing to 
anxiety problems.  
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